|
Pathological cases |
||||||||
| Reference N = 36 |
Clozapine N = 6 |
Risperidone N = 20 |
Olanzapine N = 31 |
Quetiapine N = 19 |
chi-s |
df |
P |
|
|
|
||||||||
| Hyperglycaemia (110 ≤ glycaemia ≤ 125.9 mg/dl) |
1 (3%) |
2 (33%) |
2 (10%) |
2(7%) |
4 (22%) |
8.9 |
4 |
0.06 |
| Diabetes (glycaemia ≥126 mg/dl) |
1(5%) |
2(6.5%) |
1(5%) |
2.6 |
4 |
0.6 |
||
| Hypercholesterolemia (cholesterolemia ≥200 mg/dl) |
22 (61%) |
4 (67%) |
10 (50%) |
18 (58%) |
16 (84%) |
5.5 |
4 |
0.241 |
| Hypertriglyceridemia (triglyceridemia ≥150 mg/dl) |
5 (14%) |
5 (83%) |
9 (45%) |
7 (23%) |
10 (53%) |
18.2 |
4 |
0.001 |
| Overweight (25 ≤ BMI ≤ 29.9) |
1 (17)% |
7 (39%) |
13 (42%) |
11 (58%) |
4.5 |
3 |
0.2 |
|
| Obesity (BMI≥ 30) |
5 (83%) |
7 (39%) |
6 (19%) |
6 (32%) |
15.8 |
3 |
0.015 |
|
Tarricone et al. BMC Psychiatry 2006 6:11 doi:10.1186/1471-244X-6-11 |
||||||||